According to the research report titled ‘Global Blood Transfusion Diagnostics Market - Analysis By Product (Kits and Reagents, Instruments), Application (Disease Screening, Blood Grouping), End User, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)’, available with Market Study Report LLC, global blood transfusion diagnostics market was worth USD 2192.55 million in 2020 and is touted to register remarkable gains over the forecast period 2021-2026.
 

As cited by the report, surging demand for donor screening as well as rising incidence of chronic diseases are the primary factors driving global blood transfusion diagnostics market growth. Furthermore, growing instances of road accidents and trauma is also bolstering overall market remuneration.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3733202/
 

Ever-increasing number of surgeries performed for treating chronic illnesses such as sickle cell anemia, aplastic anemia, and leukemia is prompting major players to increase R&D activities for development of advanced instruments in hospitals and blood banks, which is positively swaying the industry outlook.
 

Notably, the field of blood transfusion diagnostics continues to evolve with the emergence of new infectious agents and increased cognizance of non-infectious risks of transfusion. Continuous improvements in treatment methods is being made to understand and reduce risks among critically ill patients.
 

Elaborating on the impact of COVID-19 pandemic, viral outbreak has precipitated a series of plasma transfusion trials in countries such as the United States, which is likely to provide several new opportunities for industry partakers over the forthcoming years.
 

On geographical front, the research literature classifies global blood transfusion diagnostics industry space into North America (United States, Canada), Europe (Germany, France, U.K, Italy), and Asia Pacific (China, India, Japan, South Korea).
 

Speaking of competitive landscape, Promega Corp., Quest Diagnostics Inc., Hologic Inc., Danaher Corp., Ortho Clinical Diagnostics, F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., and Abbott Laboratories are the prominent companies influencing global blood transfusion diagnostics market development. The report provides a thorough analysis of strategic developments in the industry, such as mergers, acquisitions, and new product offerings incorporated by these players.